WEB OF SCIENCE
SCOPUS
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee, Hyun-ju | - |
| dc.contributor.author | Jeong, Yoo Joo | - |
| dc.contributor.author | Kim, Jun-Su | - |
| dc.contributor.author | Kim, Seung-Jae | - |
| dc.contributor.author | Jo, Unhui | - |
| dc.contributor.author | Jun, Su Jin | - |
| dc.contributor.author | Lim, Jongmin | - |
| dc.contributor.author | Park, Jin-Yeop | - |
| dc.contributor.author | Lee, Myungji | - |
| dc.contributor.author | Kim, Donggi | - |
| dc.contributor.author | Song, Jeong-Heon | - |
| dc.contributor.author | Hoe, Hyang-Sook | - |
| dc.date.accessioned | 2025-04-01T14:40:11Z | - |
| dc.date.available | 2025-04-01T14:40:11Z | - |
| dc.date.created | 2025-03-20 | - |
| dc.date.issued | 2025-06 | - |
| dc.identifier.issn | 0009-9236 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.11750/58205 | - |
| dc.description.abstract | Innovations in digital technologies have emerged digital therapeutics (DTx) as a novel therapeutic intervention. DTx hold potential as novel theragnostics for disorders with broad diagnostic spectra, including neurodevelopmental diseases (NDDs). In this review, we highlight challenging factors in the successful development and deployment of DTx for NDDs with respect to patients, medical professionals, and manufacturers. We also discuss the implications of these factors and future directions for revitalizing DTx development for NDDs. | - |
| dc.language | English | - |
| dc.publisher | Wiley | - |
| dc.title | Current Status and Future Directions in the Development of Digital Therapeutic Interventions for Neurodevelopmental Disorders | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.1002/cpt.3633 | - |
| dc.identifier.wosid | 001441393900001 | - |
| dc.identifier.scopusid | 2-s2.0-86000513232 | - |
| dc.identifier.bibliographicCitation | Lee, Hyun-ju. (2025-06). Current Status and Future Directions in the Development of Digital Therapeutic Interventions for Neurodevelopmental Disorders. Clinical Pharmacology and Therapeutics, 117(6), 1632–1636. doi: 10.1002/cpt.3633 | - |
| dc.description.isOpenAccess | TRUE | - |
| dc.subject.keywordPlus | AUTISM SPECTRUM DISORDER | - |
| dc.citation.endPage | 1636 | - |
| dc.citation.number | 6 | - |
| dc.citation.startPage | 1632 | - |
| dc.citation.title | Clinical Pharmacology and Therapeutics | - |
| dc.citation.volume | 117 | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.type.docType | Review | - |
